About Isracann Biosciences

Isracann Biosciences Inc., through its subsidiaries, engages in the medical cannabis cultivation to provide products to the Israeli medical cannabis market. The company, through Cannisra Crops Ltd. (CCL), plans to use the four greenhouses for the cultivation of cannabis plants. The company focuses on becoming a supplier of dried cannabis flowers in Israel. In addition, the company, through its wholly-owned subsidiaries, will provide a range of services to CCL, including property development services, facility design and construction services, cultivation and processing services, administrative services, and technology licensing. Branding and Marketing The company intends to establish individual sales representatives to approach manufacturers and through building relationships with these firms, convert them into long-term contract customers. The main target market for the company are manufacturers or processors of cannabis products. History The company was founded in 2010. It was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in 2019.